Lilly to pay CSL $100M to license monoclonal antibody targeting IL-6

Original source ↗ | February 18, 2026 at 11:15 UTC | Finnhub - LLY

No analysis available.

Ticker	Direction	Speaker	Thesis	Time
LLY	NONE	Finnhub News	—	—